85 related articles for article (PubMed ID: 34860880)
1. Rabbit Syndrome Likely Induced by Escitalopram: A Case Report.
Nimber JS; Aggarwal A
J Pharm Technol; 2014 Oct; 30(5):179-181. PubMed ID: 34860880
[No Abstract] [Full Text] [Related]
2. Escitalopram-induced Parkinsonism.
Ak S; Anıl Yağcıoğlu AE
Gen Hosp Psychiatry; 2014; 36(1):126.e1-2. PubMed ID: 24176515
[TBL] [Abstract][Full Text] [Related]
3. Neonatal Toxicity From Escitalopram Use
Degiacomo J; Luedtke S
J Pediatr Pharmacol Ther; 2016; 21(6):522-526. PubMed ID: 28018155
[TBL] [Abstract][Full Text] [Related]
4. Serotonin syndrome caused by a CYP2C19-mediated interaction between low-dose escitalopram and clopidogrel: a case report.
Wu J; Yu J; Qu K; Yin J; Zhu C; Liu X
Front Psychiatry; 2023; 14():1257984. PubMed ID: 37886119
[TBL] [Abstract][Full Text] [Related]
5. Serotonin syndrome induced by the readministration of escitalopram after a short-term interruption in an elderly woman with depression: a case report.
Sato Y; Nakamura K; Yasui-Furukori N
Neuropsychiatr Dis Treat; 2015; 11():2505-7. PubMed ID: 26491328
[TBL] [Abstract][Full Text] [Related]
6. Escitalopram-induced liver injury: A case report and review of literature.
Ng QX; Yong CSK; Loke W; Yeo WS; Soh AYS
World J Hepatol; 2019 Oct; 11(10):719-724. PubMed ID: 31749902
[TBL] [Abstract][Full Text] [Related]
7. Escitalopram-induced epistaxis: A case report.
AlJhani SA
J Taibah Univ Med Sci; 2021 Dec; 16(6):938-942. PubMed ID: 34899137
[TBL] [Abstract][Full Text] [Related]
8. [Antipsychotics in bipolar disorders].
Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
[TBL] [Abstract][Full Text] [Related]
9. [Clinical efficacy and achievement of a complete remission in depression: increasing interest in treatment with escitalopram].
Favré P
Encephale; 2012 Feb; 38(1):86-96. PubMed ID: 22381728
[TBL] [Abstract][Full Text] [Related]
10. Escitalopram for the management of major depressive disorder: a review of its efficacy, safety, and patient acceptability.
Kirino E
Patient Prefer Adherence; 2012; 6():853-61. PubMed ID: 23271894
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological and clinical profile of newer antidepressants: implications for the treatment of elderly patients.
Dolder C; Nelson M; Stump A
Drugs Aging; 2010 Aug; 27(8):625-40. PubMed ID: 20658791
[TBL] [Abstract][Full Text] [Related]
12. Double-blind comparison of escitalopram and duloxetine in the acute treatment of major depressive disorder.
Khan A; Bose A; Alexopoulos GS; Gommoll C; Li D; Gandhi C
Clin Drug Investig; 2007; 27(7):481-92. PubMed ID: 17563128
[TBL] [Abstract][Full Text] [Related]
13. Escitalopram: a pharmacoeconomic review of its use in depression.
Croom KF; Plosker GL
Pharmacoeconomics; 2003; 21(16):1185-209. PubMed ID: 14594439
[TBL] [Abstract][Full Text] [Related]
14. Noradrenergic augmentation of escitalopram response by risperidone: electrophysiologic studies in the rat brain.
Dremencov E; El Mansari M; Blier P
Biol Psychiatry; 2007 Mar; 61(5):671-8. PubMed ID: 16934772
[TBL] [Abstract][Full Text] [Related]
15. A case of galactorrhea associated with excitalopram.
Shim SH; Lee YJ; Lee EC
Psychiatry Investig; 2009 Sep; 6(3):230-2. PubMed ID: 20046401
[TBL] [Abstract][Full Text] [Related]
16. Severe hyponatremia associated with escitalopram.
Rawal G; Kumar R; Yadav S
J Family Med Prim Care; 2017; 6(2):453-454. PubMed ID: 29302568
[TBL] [Abstract][Full Text] [Related]
17. Escitalopram tolerability as mono- versus augmentative therapy in patients with affective disorders: a naturalistic study.
Dell'osso B; Arici C; Dobrea C; Camuri G; Benatti B; Altamura AC
Neuropsychiatr Dis Treat; 2013; 9():205-9. PubMed ID: 23429980
[TBL] [Abstract][Full Text] [Related]
18. The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopram.
O'Brien FE; O'Connor RM; Clarke G; Donovan MD; Dinan TG; Griffin BT; Cryan JF
Behav Brain Res; 2014 Mar; 261():17-25. PubMed ID: 24280122
[TBL] [Abstract][Full Text] [Related]
19. The role of selective serotonin reuptake inhibitors in preventing relapse of major depressive disorder.
Clevenger SS; Malhotra D; Dang J; Vanle B; IsHak WW
Ther Adv Psychopharmacol; 2018 Jan; 8(1):49-58. PubMed ID: 29344343
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
